Groves Regina E insider trades
Groves Regina E has filed 14 Form 4s with the SEC that we hold, for AtriCure, Inc. (ATRC) (Director) and Fulgent Genetics, Inc. (FLGT) (Director). Across all of them we count 1 purchase worth $2.6K and 3 sales worth $614.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($288.1K). The largest single trade was a sale of 5,313 shares of AtriCure, Inc. worth $288.1K, dated 2026-09-11. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-17 and the latest 2026-09-14.
AtriCure, Inc. (ATRC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-04-30 | P, purchase reported on Form 4 | 34 | $2.6K | 2021-10-29 |
| 2021-09-15 | S, sale reported on Form 4 | 3,156 | $235.8K | 2021-09-17 |
| 2025-08-06 | S, sale reported on Form 4 | 2,452 | $90.3K | 2025-08-08 |
| 2026-09-11 | S, sale reported on Form 4 | 5,313 | $288.1K | 2026-09-14 |
Fulgent Genetics, Inc. (FLGT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1653877) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms